Literature DB >> 2295129

Monoclonal antibody-based immunoassay for the determination of cellular enzymatic activity for repair of specific carcinogen-DNA adducts (O6-alkylguanine).

P Nehls1, M F Rajewsky.   

Abstract

We describe a rapid and sensitive, monoclonal antibody (mAb)-based immunoassay that permits the quantitation of cellular enzymatic activity for repair of specific carcinogen-DNA adducts. The assay was established on the basis of the observation that complexes between an anti-(O6-ethyl-2'-deoxyguanosine) mAb (mAb ER-6) and O6-ethylguanine (O6-EtGua) residues in double-stranded DNA can be immobilized on nitrocellulose filters. Circular pSV2gpt plasmid DNA was linearized by digestion with EcoRI and reacted with N-ethyl-N-nitrosourea in vitro to a level of about one O6-EtGua residue per DNA molecule, labeled with 32P, and subsequently incubated with extracts prepared from L929 mouse fibroblasts and with mAb ER-6. The amount of repaired O6-EtGua is proportional to the decrease in 32P activity retained on the filters. Maximum O6-alkyl-guanine repair activity requires preparation of the cell extracts in the presence of high (approximately 0.5 M) NaCl concentrations, whereas the repair reaction per se is markedly inhibited by NaCl. Under the conditions used, the detection limit of the assay is approximately 1 x 10(-16) mol of repaired O6-alkylGua. The repair reaction followed second-order kinetics, indicating that O6-EtGua is predominantly repaired by an enzyme activity inactivated by the repair reaction (e.g. via an alkyl group transfer mechanism analogous to that exhibited by the alkyl group accepting cysteine residues of the 'suicidal' bacterial ogt and ada proteins). The data obtained from the assay can be used for computation of the relative enzymatic repair activity of a given cell extract and of the rate constant K (1 x mol-1 x s-1) of the repair reaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295129     DOI: 10.1093/carcin/11.1.81

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  After X-irradiation a transient arrest of L929 cells in G2-phase coincides with a rapid elevation of the level of O6-alkylguanine-DNA alkyltransferase.

Authors:  P Nehls; D van Beuningen; M Karwowski
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

2.  Repair of O6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea.

Authors:  J Thomale; N H Huh; P Nehls; G Eberle; M F Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Binding and repair of O6-ethylguanine in double-stranded oligodeoxynucleotides by recombinant human O6-alkylguanine-DNA alkyltransferase do not exhibit significant dependence on sequence context.

Authors:  K Bender; M Federwisch; U Loggen; P Nehls; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

4.  Assessment of DNA damage and repair in specific genomic regions by quantitative immuno-coupled PCR.

Authors:  M F Denissenko; S Venkatachalam; E F Yamasaki; A A Wani
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Monoclonal antibody-based, selective isolation of DNA fragments containing an alkylated base to be quantified in defined gene sequences.

Authors:  K Hochleitner; J Thomale; M F Rajewsky
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

6.  Formation and persistence of 8-oxoguanine in rat lung cells as an important determinant for tumor formation following particle exposure.

Authors:  P Nehls; F Seiler; B Rehn; R Greferath; J Bruch
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

7.  Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level.

Authors:  J Thomale; F Seiler; M R Müller; S Seeber; M F Rajewsky
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.